Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer

Recruiting N/A Interventional Study
Lung Cancers
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
240 (estimated)
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will be an evaluation of the efficacy and safety of acupuncture to enhance the response rate of immunotherapy in advanced lung cancer. The main questions it aims to answer are 1. Does acupuncture heighten the response rate of immunotherapy in advanced lung cancer? 2. Does acupuncture heighten the safety of immunotherapy in advanced lung cancer? Researchers will compare acupuncture to sh…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria: * Age 18-75 years; * ECOG/PS score of grade 0-1 and expected survival ≥ 3 months; * Non-small cell lung cancer AJCC lung cancer staging of stage IIIB-IV, or small cell lung cancer staging of extensive stage; * PD-L1 immunohistochemistry detection of tumor cell positive proportio…
Contacts

Jiarong FAN

86+88001196

fjrr1115@163.com

CONTACT